share_log

Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More

Benzinga ·  Jan 27 10:00

New Study Reveals Suggestibility's Role In Antidepressant Effects Of Psilocybin Therapy

A new study led byBalázs Szigetiand with involvement of researchersBrandon Weiss, Fernando E Rosas, David Erritzoe, David Nutt and Robin Carhart-Harrisfound evidence of suggestibility predicting an antidepressant response for patients receiving psilocybin therapy.

The study aimed to understand the link between pre-trial expectancy, suggestibility and response to treatment in a previously conducted clinical trial comparing escitalopram andCOMPASS Pathways' (NASDAQ:CMPS) synthetic psilocybin, COMP360, in the treatment of 55 patients with Major Depressive Disorder (MDD.)Read more HERE.

EU Allocates Funds To Study...

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment